Ignite Creation Date:
2024-05-06 @ 7:43 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06118593
Status:
COMPLETED
Last Update Posted:
2024-02-06
First Post:
2023-11-01
Brief Title:
Why in Hospital After Wedge Resection
Sponsor:
Rigshospitalet Denmark
Organization:
Rigshospitalet Denmark
Study Overview
Official Title:
Why in Hospital After ERAS VATS Wedge Resection
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In the realm of lung surgery video-assisted thoracoscopic surgery VATS offers distinct advantages including shorter hospital stays reduced pain improved quality of life and increased postoperative mobility when compared to thoracotomy Additionally the enhanced recovery after surgery ERAS protocol in lung surgery characterized by a comprehensive multidisciplinary approach have streamlined postoperative recovery resulting in early discharge and diminished postoperative complications However drawing from our extensive experience with fully implemented ERAS VATS for patients undergoing pulmonary lobectomy we observed that approximately 45 of patients did not experience early discharge
Based on existing evidence the length of stay LOS following wedge resection typically ranges from 3 to 6 days across various regions including Europe the United States and China However there is a notable lack of procedure-specific data for ERAS VATS wedge resection to explore reasons of delaying discharge This prompts us to undertake an investigation into individuals following pulmonary wedge resection under the same ERAS programs
Based on existing evidence the length of stay LOS following wedge resection typically ranges from 3 to 6 days across various regions including Europe the United States and China However there is a notable lack of procedure-specific data for ERAS VATS wedge resection to explore reasons of delaying discharge This prompts us to undertake an investigation into individuals following pulmonary wedge resection under the same ERAS programs
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None